5:40 PM
 | 
Jun 13, 2014
 |  BC Extra  |  Financial News

Amphastar sets IPO range

Generics company Amphastar Pharmaceuticals Inc. (Rancho Cucamonga, Calif.) amended its IPO on NASDAQ and now hopes to sell 4 million shares at $10-$12. At the $11...

Read the full 112 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >